Attitudes of Potential Participants Towards Potential Gene Therapy Trials in Autosomal Dominant Progressive Sensorineural Hearing Loss
暂无分享,去创建一个
E. van Wijk | R. Pennings | V. van Rompaey | O. Vanderveken | R. van de Berg | V. Topsakal | E. de Vrieze | P. Ponsaerts | G. Van Camp | S. Janssens de Varebeke | J. Moyaert | Dorien Verdoodt | Camille Levie | Julie Moyaert
[1] V. Rompaey. Making the Case for Research on Disease-Modifying Treatments to Tackle Post-lingual Progressive Sensorineural Hearing Loss. , 2020 .
[2] V. van Rompaey. Making the Case for Research on Disease-Modifying Treatments to Tackle Post-lingual Progressive Sensorineural Hearing Loss , 2020, Frontiers in Neurology.
[3] M. De Bodt,et al. Severe Hearing Loss in the Aging Population Poses a Global Public Health Challenge. How Can We Better Realize the Benefits of Cochlear Implantation to Mitigate This Crisis? , 2019, Front. Public Health.
[4] K. Stankovic,et al. Gene Therapy for Human Sensorineural Hearing Loss , 2019, Front. Cell. Neurosci..
[5] C. Morton,et al. Gene therapy for hearing loss. , 2019, Human molecular genetics.
[6] Richard J. H. Smith,et al. Targeted Allele Suppression Prevents Progressive Hearing Loss in the Mature Murine Model of Human TMC1 Deafness. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.
[7] V. van Rompaey,et al. A systematic review of hearing and vestibular function in carriers of the Pro51Ser mutation in the COCH gene , 2019, European Archives of Oto-Rhino-Laryngology.
[8] P. van de Heyning,et al. Impaired Cognitive Functioning in Cochlear Implant Recipients Over the Age of 55 Years: A Cross-Sectional Study Using the Repeatable Battery for the Assessment of Neuropsychological Status for Hearing-Impaired Individuals (RBANS-H) , 2018, Front. Neurosci..
[9] V. van Rompaey,et al. author-version of: Cognitive outcomes after cochlear implantation in older adults : a systematic review , 2022 .
[10] H. Kingma,et al. Full Spectrum of Reported Symptoms of Bilateral Vestibulopathy Needs Further Investigation—A Systematic Review , 2018, Front. Neurol..
[11] P. van de Heyning,et al. Does Otovestibular Loss in the Autosomal Dominant Disorder DFNA9 Have an Impact of on Cognition? A Systematic Review , 2018, Front. Neurosci..
[12] Xuan Zhang,et al. Hearing Impairment, Mild Cognitive Impairment, and Dementia: A Meta-Analysis of Cohort Studies , 2017, Dementia and Geriatric Cognitive Disorders Extra.
[13] P. Avan,et al. Local gene therapy durably restores vestibular function in a mouse model of Usher syndrome type 1G , 2017, Proceedings of the National Academy of Sciences.
[14] J. R. Holt,et al. Gene Therapy Restores Auditory and Vestibular Function in a Mouse Model of Usher Syndrome Type 1c , 2017, Nature Biotechnology.
[15] Y. Smulders,et al. Agreement between health utility instruments in cochlear implantation , 2016, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.
[16] J. Graham,et al. International survey of cochlear implant candidacy , 2016, Cochlear implants international.
[17] P. Parizel,et al. Semicircular Canal Fibrosis as a Biomarker for Lateral Semicircular Canal Function Loss , 2016, Front. Neurol..
[18] C. Buchman,et al. Cochlear Implant Access in Six Developed Countries , 2016, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.
[19] E. Mylanus,et al. Cost–Utility of Bilateral Versus Unilateral Cochlear Implantation in Adults: A Randomized Controlled Trial , 2016, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.
[20] Maura K. Cosetti,et al. Is cochlear implantation safe and effective in the elderly? , 2015, The Laryngoscope.
[21] P. Govaerts,et al. Focal Sclerosis of Semicircular Canals With Severe DFNA9 Hearing Impairment Caused by a P51S COCH-Mutation: Is There a Link? , 2014, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.
[22] T. Yang,et al. Clinical characterization of a novel COCH mutation G87V in a Chinese DFNA9 family. , 2013, International journal of pediatric otorhinolaryngology.
[23] T. Hoppitt,et al. Health-related quality of life and supportive care in patients with rare long-term neurological conditions , 2013, Quality of Life Research.
[24] A. Ishiyama,et al. Cochlin expression in vestibular endorgans obtained from patients with Meniere’s disease , 2012, Cell and Tissue Research.
[25] A. Ho,et al. Health-related quality of life in Huntington’s disease patients: a comparison of proxy assessment and patient self-rating using the disease-specific Huntington’s disease health-related quality of life questionnaire (HDQoL) , 2012, Journal of Neurology.
[26] R. Anderson,et al. Systematic reviews of the effectiveness and cost‐effectiveness of multi‐channel unilateral cochlear implants for adults , 2010, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.
[27] R. Häusler,et al. Prospective Effectiveness of Stapes Surgery for Otosclerosis in a Multicenter Audit Setting: Feasibility of the Common Otology Database as a Benchmark Database , 2009, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.
[28] D. Brough,et al. Adenoviral vectors for improved gene delivery to the inner ear , 2009, Hearing Research.
[29] C. Morton,et al. A targeted Coch missense mutation: a knock-in mouse model for DFNA9 late-onset hearing loss and vestibular dysfunction. , 2008, Human molecular genetics.
[30] Susan Persky,et al. Assessing hypothetical scenario methodology in genetic susceptibility testing analog studies: a quantitative review , 2007, Genetics in Medicine.
[31] C. Cremers,et al. Vestibular Deterioration Precedes Hearing Deterioration in the P51S COCH Mutation (DFNA9): An Analysis in 74 Mutation Carriers , 2005, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.
[32] C. Cremers,et al. Audiometric, Vestibular, and Genetic Aspects of a DFNA9 Family with a G88E COCH Mutation , 2005, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.
[33] C. Cremers,et al. Cross-Sectional Analysis of Hearing Threshold in Relation to Age in a Large Family with Cochleovestibular Impairment Thoroughly Genotyped for DFNA9/COCH , 2003, The Annals of otology, rhinology, and laryngology.
[34] C. Cremers,et al. Non-syndromal autosomal dominant hearing impairment: ongoing phenotypical characterization of genotypes. , 1999, British journal of audiology.
[35] C. Cremers,et al. Progressive Cochleovestibular Impairment Caused by a Point Mutation in the COCH Gene at DFNA9 , 1999, The Laryngoscope.